Treatment Horizons

The 6th IAS Pathogenesis Conference doesn't really end after the closing session by David Miller In 1987 I attended my first AIDS conference, beginning twenty-four years...

Stronger Punch? Monoclonal antibodies provide new hope for easier dosing by Jeannie Wraight With multi-drug, once-a-day therapies now available for use, the push for additional easier to...

A statin challenges the drug interaction status quo by Chael Needle LifeGuide Maintaining appropriate levels of lipids (fats or fat-like substances in the blood)—“good” cholesterol (HDL-C),...

LifeGuide Therapeutic Vaccines May Change the Treatment Landscape for the Better by Jeannie Gibbs Clinical development of HIV therapeutic vaccine candidate, Vacc-4x, will continue after further...

Treatment Horizons by Chael Needle A nonprofit creates a new support system for the uninsured Joining Merck and ViiV Healthcare, Gilead Sciences is now supporting and...

Therapeutic Vaccine Research Toward a Functional Cure Shows Promise by Jeannie Wraight Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...

Study results show immediate treatment holds promise as a prevention tool by Chael Needle Treatment and prevention make good bedfellows. That’s the idea underscoring the results...

Not So Complicated Alisson Sombredero, MD, offers to physicians compelling approaches to HIV care by Chael Needle Alisson Sombredero, MD, is more than two months into her...

An extended release formulation breaks through by Chael Needle Based on results from the VERxVE study, the FDA recently approved Viramune XR for use in antiretroviral...

Natasha Travis, MD, helps shape the HIV learning curve for physicians and patients by Chael Needle Awarded a 2012 Minority Clinical Fellowship by the HIV Medicine...